Abstract P2-09-33: Validity of Bone Marker Measurements for Monitoring Response to Bisphosphonate (BP) Therapy with Zoledronic Acid (ZOL) in Metastatic Breast Cancer (mBC): Useful or Not?

@inproceedings{Aktas2010AbstractPV,
  title={Abstract P2-09-33: Validity of Bone Marker Measurements for Monitoring Response to Bisphosphonate (BP) Therapy with Zoledronic Acid (ZOL) in Metastatic Breast Cancer (mBC): Useful or Not?},
  author={Bahriye Aktas and Sabine Kasimir-Bauer and Nils Lehmann and Rainer Kimmig and Sherko K{\"u}mmel},
  year={2010}
}

Topics from this paper.